Reproductive and Lifestyle Factors and Circulating sRANKL and OPG Concentrations in Women: Results from the EPIC Cohort

Danja Sarink, Jiaxi Yang, Theron Johnson, Jenny Chang-Claude, Kim Overvad, Anja Olsen, Anne Tjønneland, Agnès Fournier, Francesca Romana Mancini, Marina Kvaskoff, Heiner Boeing, Antonia Trichopoulou, Anna Karakatsani, Elissavet Valanou, Claudia Agnoli, Carlotta Sacerdote, Giovanna Masala, Amalia Mattiello, Rosario Tumino, Carla H. Van GilsGuri Skeie, Inger Torhild Gram, Elisabete Weiderpass, Leila Lujan-Barroso, Dafina Petrova, Carmen Santiuste, J. Ramón Quirós, Aurelio Barricarte, Pilar Amiano, Ruth C. Travis, Marc Gunter, Laure Dossus, Sofia Christakoudi, Rudolf Kaaks, Renée Turzanski Fortner

Research output: Contribution to journalArticle

Abstract

Background: Except for a documented increase in osteoprotegerin (OPG) concentrations with older age, data on determinants of soluble Receptor Activator of Nuclear Factor kB (sRANKL) and OPG concentrations in women are limited. We evaluated reproductive and lifestyle factors as potential sources of variation in circulating sRANKL and OPG concentrations in pre- and postmenopausal women. Methods: This study includes 2,016 controls [n = 1,552 (76%) postmenopausal, n = 757 (38%) using postmenopausal hormone therapy (PMH)] from a breast cancer case-control study nested in the European Prospective Investigation into Cancer and Nutrition (EPIC) cohort. Serum sRANKL was measured using an ELISA and serum OPG using an electrochemiluminescent assay. Generalized linear models were used to evaluate associations between these analytes and reproductive and lifestyle factors. Results: Older age at blood collection was associated with lower sRANKL concentrations in postmenopausal women (Ptrend < 0.03) and higher OPG concentrations in all women (Ptrend < 0.01). Longer duration of oral contraceptive use among premenopausal women and postmenopausal PMH users was associated with higher OPG (Ptrend < 0.04). In postmenopausal non-PMH users, sRANKL concentrations were lower with longer duration of oral contraceptive use and current (vs. never) smoking (P < 0.01). sRANKL concentrations were higher among women with higher BMI (Ptrend < 0.01). The evaluated factors accounted for 12% of the variation in sRANKL concentrations and 21% of the variation in OPG concentrations. Conclusions: Circulating sRANKL and OPG concentrations are minimally impacted by hormone-related factors in pre- and postmenopausal women. Impact: This study suggests circulating concentrations of sRANKL and OPG are unlikely to be strongly modified by hormone-related reproductive and lifestyle factors.

Original languageEnglish
Pages (from-to)1746-1754
Number of pages9
JournalCancer Epidemiology Biomarkers and Prevention
Volume28
Issue number10
DOIs
Publication statusPublished - Jan 1 2019

Fingerprint

Osteoprotegerin
Life Style
Neoplasms
Hormones
Oral Contraceptives
Cytoplasmic and Nuclear Receptors
Serum
Case-Control Studies
Linear Models
Therapeutics
Smoking
Enzyme-Linked Immunosorbent Assay
Breast Neoplasms

ASJC Scopus subject areas

  • Epidemiology
  • Oncology

Cite this

Reproductive and Lifestyle Factors and Circulating sRANKL and OPG Concentrations in Women : Results from the EPIC Cohort. / Sarink, Danja; Yang, Jiaxi; Johnson, Theron; Chang-Claude, Jenny; Overvad, Kim; Olsen, Anja; Tjønneland, Anne; Fournier, Agnès; Mancini, Francesca Romana; Kvaskoff, Marina; Boeing, Heiner; Trichopoulou, Antonia; Karakatsani, Anna; Valanou, Elissavet; Agnoli, Claudia; Sacerdote, Carlotta; Masala, Giovanna; Mattiello, Amalia; Tumino, Rosario; Van Gils, Carla H.; Skeie, Guri; Gram, Inger Torhild; Weiderpass, Elisabete; Lujan-Barroso, Leila; Petrova, Dafina; Santiuste, Carmen; Quirós, J. Ramón; Barricarte, Aurelio; Amiano, Pilar; Travis, Ruth C.; Gunter, Marc; Dossus, Laure; Christakoudi, Sofia; Kaaks, Rudolf; Fortner, Renée Turzanski.

In: Cancer Epidemiology Biomarkers and Prevention, Vol. 28, No. 10, 01.01.2019, p. 1746-1754.

Research output: Contribution to journalArticle

Sarink, D, Yang, J, Johnson, T, Chang-Claude, J, Overvad, K, Olsen, A, Tjønneland, A, Fournier, A, Mancini, FR, Kvaskoff, M, Boeing, H, Trichopoulou, A, Karakatsani, A, Valanou, E, Agnoli, C, Sacerdote, C, Masala, G, Mattiello, A, Tumino, R, Van Gils, CH, Skeie, G, Gram, IT, Weiderpass, E, Lujan-Barroso, L, Petrova, D, Santiuste, C, Quirós, JR, Barricarte, A, Amiano, P, Travis, RC, Gunter, M, Dossus, L, Christakoudi, S, Kaaks, R & Fortner, RT 2019, 'Reproductive and Lifestyle Factors and Circulating sRANKL and OPG Concentrations in Women: Results from the EPIC Cohort', Cancer Epidemiology Biomarkers and Prevention, vol. 28, no. 10, pp. 1746-1754. https://doi.org/10.1158/1055-9965.EPI-19-0241
Sarink, Danja ; Yang, Jiaxi ; Johnson, Theron ; Chang-Claude, Jenny ; Overvad, Kim ; Olsen, Anja ; Tjønneland, Anne ; Fournier, Agnès ; Mancini, Francesca Romana ; Kvaskoff, Marina ; Boeing, Heiner ; Trichopoulou, Antonia ; Karakatsani, Anna ; Valanou, Elissavet ; Agnoli, Claudia ; Sacerdote, Carlotta ; Masala, Giovanna ; Mattiello, Amalia ; Tumino, Rosario ; Van Gils, Carla H. ; Skeie, Guri ; Gram, Inger Torhild ; Weiderpass, Elisabete ; Lujan-Barroso, Leila ; Petrova, Dafina ; Santiuste, Carmen ; Quirós, J. Ramón ; Barricarte, Aurelio ; Amiano, Pilar ; Travis, Ruth C. ; Gunter, Marc ; Dossus, Laure ; Christakoudi, Sofia ; Kaaks, Rudolf ; Fortner, Renée Turzanski. / Reproductive and Lifestyle Factors and Circulating sRANKL and OPG Concentrations in Women : Results from the EPIC Cohort. In: Cancer Epidemiology Biomarkers and Prevention. 2019 ; Vol. 28, No. 10. pp. 1746-1754.
@article{c959f4c1da5b49a0b7058ac323c47dc6,
title = "Reproductive and Lifestyle Factors and Circulating sRANKL and OPG Concentrations in Women: Results from the EPIC Cohort",
abstract = "Background: Except for a documented increase in osteoprotegerin (OPG) concentrations with older age, data on determinants of soluble Receptor Activator of Nuclear Factor kB (sRANKL) and OPG concentrations in women are limited. We evaluated reproductive and lifestyle factors as potential sources of variation in circulating sRANKL and OPG concentrations in pre- and postmenopausal women. Methods: This study includes 2,016 controls [n = 1,552 (76{\%}) postmenopausal, n = 757 (38{\%}) using postmenopausal hormone therapy (PMH)] from a breast cancer case-control study nested in the European Prospective Investigation into Cancer and Nutrition (EPIC) cohort. Serum sRANKL was measured using an ELISA and serum OPG using an electrochemiluminescent assay. Generalized linear models were used to evaluate associations between these analytes and reproductive and lifestyle factors. Results: Older age at blood collection was associated with lower sRANKL concentrations in postmenopausal women (Ptrend < 0.03) and higher OPG concentrations in all women (Ptrend < 0.01). Longer duration of oral contraceptive use among premenopausal women and postmenopausal PMH users was associated with higher OPG (Ptrend < 0.04). In postmenopausal non-PMH users, sRANKL concentrations were lower with longer duration of oral contraceptive use and current (vs. never) smoking (P < 0.01). sRANKL concentrations were higher among women with higher BMI (Ptrend < 0.01). The evaluated factors accounted for 12{\%} of the variation in sRANKL concentrations and 21{\%} of the variation in OPG concentrations. Conclusions: Circulating sRANKL and OPG concentrations are minimally impacted by hormone-related factors in pre- and postmenopausal women. Impact: This study suggests circulating concentrations of sRANKL and OPG are unlikely to be strongly modified by hormone-related reproductive and lifestyle factors.",
author = "Danja Sarink and Jiaxi Yang and Theron Johnson and Jenny Chang-Claude and Kim Overvad and Anja Olsen and Anne Tj{\o}nneland and Agn{\`e}s Fournier and Mancini, {Francesca Romana} and Marina Kvaskoff and Heiner Boeing and Antonia Trichopoulou and Anna Karakatsani and Elissavet Valanou and Claudia Agnoli and Carlotta Sacerdote and Giovanna Masala and Amalia Mattiello and Rosario Tumino and {Van Gils}, {Carla H.} and Guri Skeie and Gram, {Inger Torhild} and Elisabete Weiderpass and Leila Lujan-Barroso and Dafina Petrova and Carmen Santiuste and Quir{\'o}s, {J. Ram{\'o}n} and Aurelio Barricarte and Pilar Amiano and Travis, {Ruth C.} and Marc Gunter and Laure Dossus and Sofia Christakoudi and Rudolf Kaaks and Fortner, {Ren{\'e}e Turzanski}",
year = "2019",
month = "1",
day = "1",
doi = "10.1158/1055-9965.EPI-19-0241",
language = "English",
volume = "28",
pages = "1746--1754",
journal = "Cancer Epidemiology Biomarkers and Prevention",
issn = "1055-9965",
publisher = "American Association for Cancer Research Inc.",
number = "10",

}

TY - JOUR

T1 - Reproductive and Lifestyle Factors and Circulating sRANKL and OPG Concentrations in Women

T2 - Results from the EPIC Cohort

AU - Sarink, Danja

AU - Yang, Jiaxi

AU - Johnson, Theron

AU - Chang-Claude, Jenny

AU - Overvad, Kim

AU - Olsen, Anja

AU - Tjønneland, Anne

AU - Fournier, Agnès

AU - Mancini, Francesca Romana

AU - Kvaskoff, Marina

AU - Boeing, Heiner

AU - Trichopoulou, Antonia

AU - Karakatsani, Anna

AU - Valanou, Elissavet

AU - Agnoli, Claudia

AU - Sacerdote, Carlotta

AU - Masala, Giovanna

AU - Mattiello, Amalia

AU - Tumino, Rosario

AU - Van Gils, Carla H.

AU - Skeie, Guri

AU - Gram, Inger Torhild

AU - Weiderpass, Elisabete

AU - Lujan-Barroso, Leila

AU - Petrova, Dafina

AU - Santiuste, Carmen

AU - Quirós, J. Ramón

AU - Barricarte, Aurelio

AU - Amiano, Pilar

AU - Travis, Ruth C.

AU - Gunter, Marc

AU - Dossus, Laure

AU - Christakoudi, Sofia

AU - Kaaks, Rudolf

AU - Fortner, Renée Turzanski

PY - 2019/1/1

Y1 - 2019/1/1

N2 - Background: Except for a documented increase in osteoprotegerin (OPG) concentrations with older age, data on determinants of soluble Receptor Activator of Nuclear Factor kB (sRANKL) and OPG concentrations in women are limited. We evaluated reproductive and lifestyle factors as potential sources of variation in circulating sRANKL and OPG concentrations in pre- and postmenopausal women. Methods: This study includes 2,016 controls [n = 1,552 (76%) postmenopausal, n = 757 (38%) using postmenopausal hormone therapy (PMH)] from a breast cancer case-control study nested in the European Prospective Investigation into Cancer and Nutrition (EPIC) cohort. Serum sRANKL was measured using an ELISA and serum OPG using an electrochemiluminescent assay. Generalized linear models were used to evaluate associations between these analytes and reproductive and lifestyle factors. Results: Older age at blood collection was associated with lower sRANKL concentrations in postmenopausal women (Ptrend < 0.03) and higher OPG concentrations in all women (Ptrend < 0.01). Longer duration of oral contraceptive use among premenopausal women and postmenopausal PMH users was associated with higher OPG (Ptrend < 0.04). In postmenopausal non-PMH users, sRANKL concentrations were lower with longer duration of oral contraceptive use and current (vs. never) smoking (P < 0.01). sRANKL concentrations were higher among women with higher BMI (Ptrend < 0.01). The evaluated factors accounted for 12% of the variation in sRANKL concentrations and 21% of the variation in OPG concentrations. Conclusions: Circulating sRANKL and OPG concentrations are minimally impacted by hormone-related factors in pre- and postmenopausal women. Impact: This study suggests circulating concentrations of sRANKL and OPG are unlikely to be strongly modified by hormone-related reproductive and lifestyle factors.

AB - Background: Except for a documented increase in osteoprotegerin (OPG) concentrations with older age, data on determinants of soluble Receptor Activator of Nuclear Factor kB (sRANKL) and OPG concentrations in women are limited. We evaluated reproductive and lifestyle factors as potential sources of variation in circulating sRANKL and OPG concentrations in pre- and postmenopausal women. Methods: This study includes 2,016 controls [n = 1,552 (76%) postmenopausal, n = 757 (38%) using postmenopausal hormone therapy (PMH)] from a breast cancer case-control study nested in the European Prospective Investigation into Cancer and Nutrition (EPIC) cohort. Serum sRANKL was measured using an ELISA and serum OPG using an electrochemiluminescent assay. Generalized linear models were used to evaluate associations between these analytes and reproductive and lifestyle factors. Results: Older age at blood collection was associated with lower sRANKL concentrations in postmenopausal women (Ptrend < 0.03) and higher OPG concentrations in all women (Ptrend < 0.01). Longer duration of oral contraceptive use among premenopausal women and postmenopausal PMH users was associated with higher OPG (Ptrend < 0.04). In postmenopausal non-PMH users, sRANKL concentrations were lower with longer duration of oral contraceptive use and current (vs. never) smoking (P < 0.01). sRANKL concentrations were higher among women with higher BMI (Ptrend < 0.01). The evaluated factors accounted for 12% of the variation in sRANKL concentrations and 21% of the variation in OPG concentrations. Conclusions: Circulating sRANKL and OPG concentrations are minimally impacted by hormone-related factors in pre- and postmenopausal women. Impact: This study suggests circulating concentrations of sRANKL and OPG are unlikely to be strongly modified by hormone-related reproductive and lifestyle factors.

UR - http://www.scopus.com/inward/record.url?scp=85072849223&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85072849223&partnerID=8YFLogxK

U2 - 10.1158/1055-9965.EPI-19-0241

DO - 10.1158/1055-9965.EPI-19-0241

M3 - Article

C2 - 31292137

AN - SCOPUS:85072849223

VL - 28

SP - 1746

EP - 1754

JO - Cancer Epidemiology Biomarkers and Prevention

JF - Cancer Epidemiology Biomarkers and Prevention

SN - 1055-9965

IS - 10

ER -